These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 15790536
1. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, Lockhart P, Zhang J. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):119-38. PubMed ID: 15790536 [Abstract] [Full Text] [Related]
2. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bernardi G, Roth BL, Pothos EN, Calabresi P, Shen J. Neuron; 2005 Feb 17; 45(4):489-96. PubMed ID: 15721235 [Abstract] [Full Text] [Related]
7. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L, Garris BL, Garris DR, Lau YS. Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572 [Abstract] [Full Text] [Related]
9. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, Lees AJ. Brain; 2004 Feb 19; 127(Pt 2):420-30. PubMed ID: 14662519 [Abstract] [Full Text] [Related]
10. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Inden M, Kitamura Y, Takahashi K, Takata K, Ito N, Niwa R, Funayama R, Nishimura K, Taniguchi T, Honda T, Taira T, Ariga H. J Pharmacol Sci; 2011 Feb 19; 117(3):189-203. PubMed ID: 22041943 [Abstract] [Full Text] [Related]
12. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice. Nguyen TA, Frank-Cannon T, Martinez TN, Ruhn KA, Marvin M, Casey B, Treviño I, Hong JJ, Goldberg MS, Tansey MG. J Neuroinflammation; 2013 Apr 28; 10():50. PubMed ID: 23622116 [Abstract] [Full Text] [Related]
15. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, Ravindranath V. FASEB J; 2007 Jul 28; 21(9):2226-36. PubMed ID: 17369508 [Abstract] [Full Text] [Related]
16. TIGAR inclusion pathology is specific for Lewy body diseases. López KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR. Brain Res; 2019 Mar 01; 1706():218-223. PubMed ID: 30267647 [Abstract] [Full Text] [Related]
17. Proteomic approach to studying Parkinson's disease. Zhang J, Goodlett DR. Mol Neurobiol; 2004 Jun 01; 29(3):271-88. PubMed ID: 15181239 [Abstract] [Full Text] [Related]
18. Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment. Korecka JA, Eggers R, Swaab DF, Bossers K, Verhaagen J. Restor Neurol Neurosci; 2013 Jun 01; 31(2):155-67. PubMed ID: 23271419 [Abstract] [Full Text] [Related]
19. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Ahlskog JE. Parkinsonism Relat Disord; 2009 Dec 01; 15(10):721-7. PubMed ID: 19815446 [Abstract] [Full Text] [Related]